AxoGen Statistics

Share Statistics

AxoGen has 46.01M shares outstanding. The number of shares has increased by 3.91% in one year.

Shares Outstanding	46.01M
Shares Change (YoY)	3.91%
Shares Change (QoQ)	2.71%
Owned by Institutions (%)	85.85%
Shares Floating	43.53M
Failed to Deliver (FTD) Shares	9,378
FTD / Avg. Volume	0.88%

Short Selling Information

The latest short interest is 3.09M, so 6.78% of the outstanding shares have been sold short.

Short Interest	3.09M
Short % of Shares Out	6.78%
Short % of Float	6.98%
Short Ratio (days to cover)	3.28

Valuation Ratios

The PE ratio is -73.2 and the forward PE ratio is 28.96. AxoGen's PEG ratio is 1.33.

PE Ratio	-73.2
Forward PE	28.96
PS Ratio	3.89
Forward PS	2.5
PB Ratio	7.02
P/FCF Ratio	66306.53
PEG Ratio	1.33

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AxoGen.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.66.

Current Ratio	3.24
Quick Ratio	2.16
Debt / Equity	0.66
Debt / EBITDA	11.3
Debt / FCF	6.24K
Interest Coverage	-0.4

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$415.38K
Profits Per Employee	$-22.09K
Employee Count	451
Asset Turnover	0.92
Inventory Turnover	1.37

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 28.79% in the last 52 weeks. The beta is 0.99, so AxoGen's price volatility has been higher than the market average.

Beta	0.99
52-Week Price Change	28.79%
50-Day Moving Average	11.51
200-Day Moving Average	14.77
Relative Strength Index (RSI)	64.81
Average Volume (20 Days)	1,066,991

Income Statement

In the last 12 months, AxoGen had revenue of 187.34M and earned -9.96M in profits. Earnings per share was -0.23.

Revenue	187.34M
Gross Profit	141.98M
Operating Income	-3.29M
Net Income	-9.96M
EBITDA	6.08M
EBIT	-1.76M
Earnings Per Share (EPS)	-0.23

Full Income Statement

Balance Sheet

The company has 27.55M in cash and 68.69M in debt, giving a net cash position of -41.13M.

Cash & Cash Equivalents	27.55M
Total Debt	68.69M
Net Cash	-41.13M
Retained Earnings	-291.26M
Total Assets	205.45M
Working Capital	78.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.54M and capital expenditures -4.52M, giving a free cash flow of 11K.

Operating Cash Flow	4.54M
Capital Expenditures	-4.52M
Free Cash Flow	11K
FCF Per Share	0

Full Cash Flow Statement

Margins

Gross margin is 75.79%, with operating and profit margins of -1.75% and -5.32%.

Gross Margin	75.79%
Operating Margin	-1.75%
Pretax Margin	-5.32%
Profit Margin	-5.32%
EBITDA Margin	3.24%
EBIT Margin	-1.75%
FCF Margin	0.01%

Dividends & Yields

AXGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for AXGN is $25, which is 78.6% higher than the current price. The consensus rating is "Buy".

Price Target	$25
Price Target Difference	78.6%
Analyst Consensus	Buy
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jul 11, 1994. It was a forward split with a ratio of 21:20.

Last Split Date	Jul 11, 1994
Split Type	forward
Split Ratio	21:20

Scores

Altman Z-Score	3.6
Piotroski F-Score	5

AxoGen Inc. (AXGN)